NASDAQ:EYEN - Eyenovia Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$2.72 -0.02 (-0.73 %)
(As of 01/15/2019 04:00 PM ET)
Previous Close$2.74
Today's Range$2.68 - $2.75
52-Week Range$2.40 - $10.74
Volume21,500 shs
Average Volume29,810 shs
Market Capitalization$27.85 million
P/E Ratio-1.23
Dividend YieldN/A
BetaN/A
Eyenovia, Inc., a clinical stage biopharmaceutical company, engages in developing a pipeline of ophthalmology products in the United States. It is developing MicroProst, which is in Phase III clinical trials for the treatment of chronic angle closure glaucoma; MicroStat, which is in Phase III clinical trials for the treatment of mydriasis; MicroTears for the treatment of dry eye; and MicroPine for the treatment of myopia. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was founded in 2014 and is based in New York, New York.

Receive EYEN News and Ratings via Email

Sign-up to receive the latest news and ratings for EYEN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:EYEN
CUSIPN/A
Phone917-289-1117

Debt

Current Ratio12.41
Quick Ratio12.41

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Book Value$0.51 per share
Price / Book5.33

Profitability

Net Income$-5,120,000.00
Net MarginsN/A
Return on Assets-66.24%

Miscellaneous

EmployeesN/A
Market Cap$27.85 million
OptionableNot Optionable

Eyenovia (NASDAQ:EYEN) Frequently Asked Questions

What is Eyenovia's stock symbol?

Eyenovia trades on the NASDAQ under the ticker symbol "EYEN."

How were Eyenovia's earnings last quarter?

Eyenovia Inc (NASDAQ:EYEN) issued its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.43) earnings per share for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.43). View Eyenovia's Earnings History.

When is Eyenovia's next earnings date?

Eyenovia is scheduled to release their next quarterly earnings announcement on Monday, April 1st 2019. View Earnings Estimates for Eyenovia.

What price target have analysts set for EYEN?

3 equities research analysts have issued 12-month target prices for Eyenovia's shares. Their predictions range from $12.00 to $35.00. On average, they anticipate Eyenovia's share price to reach $22.3333 in the next twelve months. This suggests a possible upside of 721.1% from the stock's current price. View Analyst Price Targets for Eyenovia.

What is the consensus analysts' recommendation for Eyenovia?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eyenovia in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Eyenovia.

Has Eyenovia been receiving favorable news coverage?

News stories about EYEN stock have trended somewhat positive on Tuesday, according to InfoTrie. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Eyenovia earned a news sentiment score of 1.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term.

Who are some of Eyenovia's key competitors?

Who are Eyenovia's key executives?

Eyenovia's management team includes the folowing people:
  • Dr. Tsontcho Ianchulev M.P.H., M.D., MPH, CEO, Chief Medical Officer & Director (Age 44)
  • Ms. Jennifer Clasby, VP of Clinical Operations (Age 64)
  • Mr. Luke Clauson, VP of R&D (Age 39)
  • Mr. John P. Gandolfo, CFO & Sec. (Age 57)
  • Mr. Michael M. Rowe, VP of Marketing

When did Eyenovia IPO?

(EYEN) raised $30 million in an IPO on Thursday, January 25th 2018. The company issued 2,700,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners​ acted as the underwriters for the IPO.

How do I buy shares of Eyenovia?

Shares of EYEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Eyenovia's stock price today?

One share of EYEN stock can currently be purchased for approximately $2.72.

How big of a company is Eyenovia?

Eyenovia has a market capitalization of $27.85 million. The company earns $-5,120,000.00 in net income (profit) each year or ($2.19) on an earnings per share basis.

What is Eyenovia's official website?

The official website for Eyenovia is http://www.eyenoviabio.com.

How can I contact Eyenovia?

Eyenovia's mailing address is 501 Fifth Avenue Suite 1404, New York NY, 10017. The company can be reached via phone at 917-289-1117 or via email at [email protected]


MarketBeat Community Rating for Eyenovia (NASDAQ EYEN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  131
MarketBeat's community ratings are surveys of what our community members think about Eyenovia and other stocks. Vote "Outperform" if you believe EYEN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EYEN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/15/2019 by MarketBeat.com Staff

Featured Article: Google Finance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel